At a glance
ClinicalIndex Comparison RecordN/ACompleted· 452 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Peripheral Use of AngioJet Rheolytic Thrombectomy With Mid-Length Catheters
In Brief
An observational study for Peripheral Vascular Diseases and 2 related conditions. Completed, enrolled 452 participants.
Detailed Summary
This registry collects observational data about how mid-length AngioJet catheters (ie XPEEDIOR and DVX models) are used in routine clinical practice.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPeripheral Vascular Diseases, Thrombosis, Venous Thrombosis
Countries--
Collaborators--
Timeline
N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJan 2007
First PostedOct 2008
Primary CompletionMar 2010
Study CompletionApr 2010
TodayJul 2026
First PostedOct 23, 2008
Enrollment StartJan 1, 2007
Primary CompletionMar 1, 2010
Study CompletionApr 1, 2010
TodayJul 2, 2026
Enrollment to primary: 3.2 yearsPosted 17.7 years ago